The evolving landscape of gene editing therapies for human genetic diseases: a twenty-year bibliometric analysis

Xinhao Zhou, Tengfei Ma, Xu Ding, Zhenzhao Luo, Changqing Yin, Zhe Lu · 2026

Read The evolving landscape of gene editing therapies for human genetic diseases: a twenty-year bibliometric analysis by Xinhao Zhou, Tengfei Ma, Xu Ding, Zhenzhao Luo, Changqing Yin, Zhe Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13272081.txt.

Description

Xinhao Zhou and coauthors chart in 2026 twenty years of gene editing therapy research for human genetic disease through a bibliometric lens. Mapping publication patterns shows how a field moves from laboratory promise toward the clinic. The team analyzed 1,571 articles and reviews published between 2005 and 2025 in two large databases.

Output grew in three waves, from early engineered nucleases through the CRISPR surge to a recent precision phase. The United States and China led production, with blood disorders such as sickle cell disease the top targets. Newer fronts include base and prime editing and AI-assisted design, while collaboration stayed mostly within national borders.

Catalog record

CREATORXinhao Zhou, Tengfei Ma, Xu Ding, Zhenzhao Luo, Changqing Yin, Zhe Lu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13272081

Browse the full library · About the Tower of Babel